Global Orthopedic Growth Factor (MedCore) Market Report 2023-2029 Featuring Medtronic, Stryker, Cerapedics, & Rebone Biomaterials - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Orthopedic Growth Factor Market Size, Share, and COVID-19 Impact Analysis 2023-2029 MedCore" report has been added to ResearchAndMarkets.com's offering.

In 2022, the global orthopedic growth factor market was valued at $860 million. This is anticipated to increase over the forecast period at a CAGR of 3.5% to reach $1.1 billion.

The orthopedic growth factor market experienced a decline in sales as a result of the Global COVID-19 pandemic. The primary reason for this decrease was the mass cancellation and postponement of scheduled procedures.

Although these changes are only temporary, and the market is expected to return to steady growth in the long run, the impact has been significant, and many companies have been forced to accept unprecedented losses in this area for 2020.

PROCEDURE NUMBERS

Aside from the decline and recovery during 2020 and 2022, associated with the delay and cancellation of elective procedures, the total number of orthopedic growth factor procedures is projected to grow at a mid-single-digit rate over the forecast period.

GLOBAL ORTHOPEDIC GROWTH FACTOR MARKET INSIGHTS

The global orthopedic growth factor market has been steadily increasing in value over the past few years. Medtronic has been the main leader in the market with its INFUSE product. However, Wright Medical has been gaining traction with its AUGMENT product line, which has seen strong growth since its inception in 2015 and the introduction of AUGMENT Injectable into the market in 2018.

GLOBAL ORTHOPEDIC GROWTH FACTOR MARKET SHARE INSIGHTS

The global orthopedic growth factor market is lead by three main companies: Medtronic, Stryker, and Cerapedics. In 2022, Medtronic was the leader in the orthopedic growth factor market. Medtronic's INFUSE product remains the gold standard for spinal fusion therapies.

DATA TYPES INCLUDED

• Unit Sales, Average Selling Prices, Market Value & Growth Trends
• Sports Medicine Procedure Volumes
• Market Forecasts Until 2029, and Historical Data to 2022
• Market Drivers & Limiters for each Sports Medicine market segment
• Competitive Analysis with Market Shares for Each Segment
• Recent Mergers & Acquisitions
• Disease Overviews and Demographic Information
• Company Profiles, Product Portfolios and SWOT for Top Competitors

Key Topics Covered:

Orthopedic Growth Factor Market

• Executive Summary
• Global Orthopedic Growth Factor Market Overview
• Competitive Analysis
• Regions Included
• Introduction
• Procedure Numbers
• Market Analysis and Forecast
• Drivers and Limiters
• Market Drivers
• Market Limiters
• Competitive Market Share Analysis

A selection of companies mentioned in this report includes

• Medtronic
• Stryker
• Cerapedics
• Rebone Biomaterials

For more information about this report visit https://www.researchandmarkets.com/r/7we9hu-orthopedic?w=4

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.